Agios Pharmaceuticals (AGIO) Q1 2026 Earnings

12FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.95
-1.82
-1.68
-1.55

Details

Expected EPS
-1.953708
Actual EPS
-1.86
Surprise EPS
0.09
Surprise Percent
+4.8%

Description

Agios Pharmaceuticals (AGIO) has reported earnings of -1.86 per share for Q1 2026.

0 Comments

Share your thoughts